2-87772238-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 0P and 1B. BP4
The NM_001078170.3(RGPD2):c.5167C>T(p.Leu1723Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001078170.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00 AC: 5AN: 125948Hom.: 0 Cov.: 16 FAILED QC
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000499 AC: 63AN: 1263376Hom.: 0 Cov.: 19 AF XY: 0.0000394 AC XY: 25AN XY: 634244
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000397 AC: 5AN: 125948Hom.: 0 Cov.: 16 AF XY: 0.0000664 AC XY: 4AN XY: 60272
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.5167C>T (p.L1723F) alteration is located in exon 22 (coding exon 22) of the RGPD2 gene. This alteration results from a C to T substitution at nucleotide position 5167, causing the leucine (L) at amino acid position 1723 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at